Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Ruxolitinib can help regrow hair in severe alopecia areata.

An 80-year-old man grew extra hair on his forearms after starting Alzheimer's medication rivastigmine.

A blood pressure drug, diltiazem, may also help treat influenza.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Sacituzumab Tirumotecan shows promise in treating gynecologic cancers with manageable side effects.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

JW0061 may be a new treatment for hair loss by promoting hair growth through WNT signaling.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Compound 4 is a promising treatment for hair loss with low toxicity.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

QLT0267 stops hair follicle cell growth and movement.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

A new drug strategy improves hair loss treatment with better results and safety.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

The compound 4c showed strong potential as an anticancer agent.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

MK-5108 is safe and shows potential against tumors, especially alone.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.